Coronary Heart Disease How long should Platelet Aggregation Inhibition be performed?

被引：0
|
作者：
Krome, Susanne
机构：
来源：
AKTUELLE KARDIOLOGIE | 2014年 / 3卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：218 / 218
页数：1
相关论文
共 50 条
  • [21] Aspirin resistance and platelet aggregation in heart disease
    Dawson, G
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2004, 96 (10) : 1268 - 1268
  • [22] PLATELET-AGGREGATION IN HEART-DISEASE
    OVERSOHL, K
    THEISS, W
    SO, CS
    SEIDL, KF
    THROMBOSIS AND HAEMOSTASIS, 1977, 38 (01) : 270 - 270
  • [23] Platelet activation in coronary heart disease
    Wysocka, J
    Radziwon, PM
    Lipska, A
    Zelazowska, B
    Ratomski, K
    EUROMEDLAB 2003: PROCEEDINGS OF THE 15TH IFCC-FESCC EUROPEAN CONGRESS OF CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, : 991 - 993
  • [24] SHOULD CORONARY ANGIOGRAPHY BE PERFORMED IN ALL PATIENTS WHO UNDERGO CATHETERIZATION FOR VALVULAR HEART-DISEASE
    ACAR, J
    LUXEREAU, P
    VAHANIAN, A
    DUCIMETIERE, P
    BERDAH, J
    AOUATE, P
    SIENCZEWSKI, JA
    ROGER, V
    ZEITSCHRIFT FUR KARDIOLOGIE, 1986, 75 : 53 - 60
  • [25] Platelet aggregation is dependent on platelet count in patients with coronary artery disease
    Wurtz, Morten
    Hvas, Anne-Mette
    Kristensen, Steen Dalby
    Grove, Erik Lerkevang
    THROMBOSIS RESEARCH, 2012, 129 (01) : 56 - 61
  • [26] Evaluation Of Platelet Aggregation Activity Depending on The Duration of Antiplatelet Administration in Patients with Coronary Heart Disease
    Iskandarovna, Khodzhanova Shakhnoza
    JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS, 2022, 13 : 754 - 760
  • [27] EFFECTS OF LIPIDS ON PLATELET-AGGREGATION IN BLOOD FROM PATIENTS WITH CORONARY HEART-DISEASE
    BORNIKOV, VT
    ZAINUTDINOV, BR
    ISHANKHODZHAYEV, TM
    SAATOV, TS
    AKMALOV, DM
    KARDIOLOGIYA, 1989, 29 (06) : 22 - 24
  • [28] Vaccination in Patients With Heart Disease. How Long Should We Wait?
    Barrios, Vivencio
    Escobar, Carlos
    REVISTA ESPANOLA DE CARDIOLOGIA, 2019, 72 (06): : 515 - 515
  • [29] ASSESSMENT OF COMORBIDITY IN PSORIATIC DISEASE: HOW OFTEN SHOULD BE PERFORMED?
    Carmona, L.
    Torre-Alonso, J. C.
    Moreno, M.
    Galindez, E.
    Babio, J.
    Zarco, P.
    Linares, L. F.
    Collantes, E.
    Fernandez-Barrial, M.
    Hermosa, J. C.
    Coto, P.
    Suarez, C.
    Almodovar, R.
    Luelmo, J.
    Carcaba, V.
    Castaneda, S.
    Oton, T.
    Curbelo, R.
    Gratacos, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 602 - 603
  • [30] How much should the resting heart rate be controlled in patients with atrial fibrillation and coronary heart disease?
    Wang, Yan-bo
    Yuan, Qing-hua
    Yuan, Jie
    Du, Zhi-Min
    Zhuang, Xiao-dong
    Liao, Xin-xue
    BMC CARDIOVASCULAR DISORDERS, 2024, 24 (01):
12345